All News
Dr. Wesley Van Voorhis has received a grant to support advancement of a promising new therapeutic candidate for cryptosporidiosis, a devastating diarrheal disease that disproportionately affects young children in low-income and middle-income countries.
In a Q&A with UW Medicine Newsroom, endocrinologist David Cummings discusses GLP-1 drugs' evidence, side effects and unknowns.
Just as traveling from time zone to time zone can cause sleep disturbances, fuzzy thinking and overall discombobulation, solar jet lag can also result in negative health effects including, potentially, an increased risk for liver cancer.
He will join the Seattle IM Residency Program leadership team as associate program director for curriculum on July 1.
Researchers are seeking enrollees (65 or older) for a new vaccine trial for Clostridioides difficile (C. diff), which causes recurrent diarrhea and abdominal pain.
The Population Health Initiative has awarded four Tier 2 pilot grants to teams representing researchers from four different University of Washington schools and colleges as well as several community-based partners.